These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36846713)

  • 41. The E3 ligase TRIM7 suppresses the tumorigenesis of gastric cancer by targeting SLC7A11.
    Chen Q; Zhang T; Zeng R; Zhang K; Li B; Zhu Z; Ma X; Zhang Y; Li L; Zhu J; Zhang G
    Sci Rep; 2024 Mar; 14(1):6655. PubMed ID: 38509147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis.
    Liu J; Yang H; Deng J; Jiang R; Meng E; Wu H
    Environ Toxicol; 2023 Jan; 38(1):115-125. PubMed ID: 36190453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.
    Li X; Xiong W; Wang Y; Li Y; Cheng X; Liu W
    Lab Invest; 2023 May; 103(5):100058. PubMed ID: 36801644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.
    Yadav P; Sharma P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
    Cancer Lett; 2021 Dec; 522():211-224. PubMed ID: 34571083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma.
    Yin Z; Liu Q; Gao Y; Wang R; Qi Y; Wang D; Chen L; Yin X; He M; Li W
    Mol Carcinog; 2024 May; 63(5):912-925. PubMed ID: 38390729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.
    Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T
    Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
    Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
    Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells.
    Zhou X; Zhao X; Wu Z; Ma Y; Li H
    Bioengineered; 2022 Apr; 13(4):10454-10466. PubMed ID: 35465835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11.
    Zhang W; Sun Y; Bai L; Zhi L; Yang Y; Zhao Q; Chen C; Qi Y; Gao W; He W; Wang L; Chen D; Fan S; Chen H; Piao HL; Qiao Q; Xu Z; Zhang J; Zhao J; Zhang S; Yin Y; Peng C; Li X; Liu Q; Liu H; Wang Y
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34609966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
    Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
    Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
    Chen M; Jiang Y; Sun Y
    Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m
    Sun S; Gao T; Pang B; Su X; Guo C; Zhang R; Pang Q
    Cell Death Dis; 2022 Jan; 13(1):73. PubMed ID: 35064112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway.
    Chen J; Zhang J; Tian W; Ge C; Su Y; Li J; Tian H
    Mol Carcinog; 2023 Jun; 62(6):833-844. PubMed ID: 36920042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression.
    Chen L; Qiao L; Bian Y; Sun X
    Biochem Biophys Res Commun; 2020 May; 526(2):293-299. PubMed ID: 32209255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis.
    Xu X; Zhang X; Wei C; Zheng D; Lu X; Yang Y; Luo A; Zhang K; Duan X; Wang Y
    Eur J Pharm Sci; 2020 Sep; 152():105450. PubMed ID: 32621966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma.
    Yu H; Zhu K; Wang M; Jiang X
    Clin Transl Sci; 2023 Oct; 16(10):1957-1971. PubMed ID: 37503932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and Prognostic Significance of Ferroptosis-related Proteins SLC7A11 and GPX4 in Renal Cell Carcinoma.
    Ren Z; Zhang X; Han J
    Protein Pept Lett; 2023; 30(10):868-876. PubMed ID: 37807410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.